No Prescription |
 |
 | ||
|
PERMITE Nix Dermal |
|
| ||
No Prescription » Prescription Drugs 13 » PERMITE Nix Dermal Nix Dermal Cream is indicated for the treatment of scabies and crab lice. Treatment of scabies:Adults and children over 2 years old should apply the cream to the skin over the whole body including the palms and soles but not the head and face. Pay particular attention to the areas between the fingers and toes (including under the finger and toe nails) wrists arm-pits external genitals and buttocks. Babies and children under 2 years old should be treated as above and also have their necks faces ears and scalps treated. Avoid the area around the mouth (as the cream could be licked off) and around the eyes. Children between 2 months and 2 years should only be treated under medical supervision.Elderly (over 65 years old) should apply as directed for adults and children over 2 years old but should also include their necks faces ears and scalps. Care must be taken to avoid applying Dermal Cream to areas close to the eyes.The cream should be left on for at least 8 hours then washed off with soap and water not more than 12 hours later. Re-apply Cream to hands if they are washed with soap and water within 8 hours of treatment. The following table shows how much cream should normally be used: Adults (including Elderly) and children over 12 years: Up to one tube. A few adults may need to use an additional tube but do not apply more than two tubes. Children aged 6 to 12 years: Up to half a tube Children aged 1 to 5 years: Up to a quarter of a tube Babies aged 2 months to 1 year: Up to an eighth of a tube The dosage recommendations given in this leaflet are only intended as a guide to treatment. Because individuals can vary so much in size you might find that you need to apply slightly more or slightly less cream to completely cover the body. This will not harm you or reduce the effectiveness of the treatment.Treatment of crab lice:Not recommended for persons under 18 years of age. The elderly should be treated under medical supervision. Adults 18 years and over: Sufficient cream should be applied to cover the pubic region peri-anal (around the anus) inner thighs down to the knees and any hair that grows up from the pubic area to the chest/stomach.One (30 g) tube is more than sufficient to treat one hairy adult. It is recommended that up to a third of a tube is used to treat the pubic region peri-anal region thighs stomach and chest. Not more than two thirds of the tube should be needed for complete treatment. For relatively hair-free individuals proportionately less cream will be required.The cream should be left on the skin for 24 hours. The treatment areas should then be thoroughly washed. Any facial hair (beards moustaches) and eyelashes should be checked for the presence of live lice and eggs. Cream should be applied to any facial hair carefully avoiding eyes. If live lice or eggs are found on the eyelashes they should be removed carefully using tweezers. Cream should not be applied to the eye lashes because the cream can cause moderate eye irritation. Buy PERMITE Nix Dermal and other Prescription Drugs 13 products online at Medstore. Buy Online at Medstore - Click Here!
About PERMITE Nix Dermal: Product Type: Prescription Drugs 13 PERMITE ( Nix Dermal Generic Permethrin ) PERMITE (Nix Dermal Generic Permethrin) Nix Dermal Generic Permethrin 5% w/v Nix Dermal Generic Permethrin PERMITE
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
